To mark this year’s International Day of Women and Girls in Science, Optimum is celebrating the remarkable women across our network by asking them: ‘If you could collaborate with any scientist (past or present) who would it be, and why?’ Their answers were as inspiring as they were diverse, from trailblazing pioneers to modern innovators, […]
Oslo, Norway, 29 January 2026: Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announces that the first patient has been enrolled at one of the newly activated sites in its Phase 2 study of Radspherin® in patients with peritoneal carcinomatosis from ovarian cancer. Read more…
What debilitating condition affects 1.5 million women in the UK, and yet takes almost nine years on average to be diagnosed? A condition that – despite the numbers it affects – is so poorly recognised that it is often mistaken for something else, or written off as unimportant? That results in pain so bad it […]
For this year’s International Day of Women and Girls in Science, Optimum is celebrating the amazing women we work with by asking them to nominate their favourite scientific advancement or innovation. The answers are broad and varying and make for an uplifting read – learn what inspired the amazing women we work with to pursue […]
Strategic investment from the Bill & Melinda Gates Foundation with additional investment from EIFO brings the total to $11.8 million The new investment extends Series A investment to about $50 million Funds will be used to expand Freya’s DYSCOVERTM platform to identify and develop microbial immunotherapies to treat bacterial vaginosis and prevent pre-term birth COPENHAGEN, Denmark and BOSTON, Nov. 19, 2024 /PRNewswire/ — Freya […]
